 "No diversion, Bharat Biotech Pune plant as per Bombay HC order: Ajit Pawar")
Maharashtra Deputy Chief Minister
Ajit Pawar on Monday dismissed the allegation that he has diverted a Bharat Biotech project of manufacturing COVID-19 vaccines to his home district Pune.
He said the plant was being set up in Pune following a Bombay High Court decision in this regard.
Pawar is the guardian minister of Pune.
Pawar issued a statement after BJP MLA from Nagpur Krishna Khopde reportedly alleged that the deputy CM diverted the project to his home district.
"The Bombay High Court itself ordered to allot a place in Manjari in Haveli taluka of Pune to Bharat Biotech for manufacturing vaccine against COVID-19. Being the guardian minister, I have discharged the responsibility of obeying the court," Pawar said.
The senior NCP leader said he would have been equally happy if Bharat Biotech was allotted a space anywhere else in the state.
"Hence, Khopde's allegation is utterly false and misleading. It's a feeble attempt at garnering publicity for a transient period," Pawar said.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app